Sources and scope
Start with the document
behind the statement.
These records have different purposes. Product pages describe an advertised preparation or offer. Study records describe particular methods and outcomes. Agency and professional sources address their own questions. Their differences stay part of the reading.
Accessed 2026-09-27
CoreAge Rx Time Out product description
Provider formula, estrogen precautions and evidence description
Read the original recordArticles using this source
- Time Out facial estriol review: start with the hormone
- Estriol facial products compared: cream, serum and disclosed placement
- Estriol face cream is an estrogen: why the wording matters
- Hydration and firmness are different claims in an estriol face cream
- The records behind a compounded estriol face cream
Accessed 2026-09-27
CoreAge Rx Time Out current public offer
Provider commercial terms and claims; no transaction or clinical assessment tested
Read the original recordArticles using this source
Accessed 2026-09-27
Midi Estriol+ Face Cream current listing
Provider product, price and advertised review pathway
Read the original recordArticles using this source
Accessed 2026-09-27
Midi Estriol+ Face Cream express record
Provider FAQ; direct HTML captures formula and pathway text omitted by extraction
Read the original recordArticles using this source
Accessed 2026-09-27
Midi estriol/DMAE/hyaluronic-acid product monograph
Provider compounded-formula record; DMAE differs from express FAQ
Read the original recordArticles using this source
Accessed 2026-09-27
Alloy M4 Face Serum Rx product record
Provider serum page and public product metadata; cream results are not serum evidence
Read the original recordArticles using this source
Accessed 2026-09-27
Alloy company account of its M4 clinical study
Provider summary updated May 29, 2026; not an independently obtained full study report
Read the original recordArticles using this source
Accessed 2026-09-27
Alloy skincare collection and study disclosures
Provider collection record; separate products and study population disclosures
Read the original recordArticles using this source
Accessed 2026-09-27
FDA: menopause and estriol information
Regulator estriol identity, nonapproval and safer-estrogen evidence limitations
Read the original recordArticles using this source
- Time Out facial estriol review: start with the hormone
- Estriol facial products compared: cream, serum and disclosed placement
- Midi Estriol+ Face Cream: a review of the actual product records
- Alloy M4 Face Serum Rx: the serum record and the cream study
- Estriol face cream is an estrogen: why the wording matters
- Hydration and firmness are different claims in an estriol face cream
- Before-and-after estriol photos: what an image can and cannot show
- The records behind a compounded estriol face cream
Accessed 2026-09-27
FDA: compounding questions and answers
Regulator explanation; not a pharmacy audit or individual legal/medical determination
Read the original recordArticles using this source
Accessed 2026-09-27
Schmidt et al.: treatment of skin aging with topical estrogens
1996 primary study abstract; full methods and individual data not reviewed
Read the original recordArticles using this source
- Time Out facial estriol review: start with the hormone
- Estriol facial products compared: cream, serum and disclosed placement
- Midi Estriol+ Face Cream: a review of the actual product records
- Estriol face cream is an estrogen: why the wording matters
- Hydration and firmness are different claims in an estriol face cream
- Before-and-after estriol photos: what an image can and cannot show
- The records behind a compounded estriol face cream
Accessed 2026-09-27
Kainz and colleagues — When applied to facial skin, does estrogen ointment have systemic effects?, 1993
Primary study abstract only; 17 participants, three-month observation and specific measured hormones
Read the original recordArticles using this source
Accessed 2026-09-27
FDA — February 12, 2026 menopausal hormone therapy labeling announcement
Official announcement for first six approved MHT products; not approval of facial estriol
Read the original recordArticles using this source
Accessed 2026-09-27
American Academy of Dermatology — Wrinkle remedies
Professional-society guidance; moisturizer and fine-line appearance scope
Read the original recordArticles using this source
Accessed 2026-09-27
American Academy of Dermatology — Skin care during menopause
Professional-society patient guidance; updated November 24, 2025
Read the original recordArticles using this source
Accessed 2026-09-27
Federal Trade Commission — Health Products Compliance Guidance
Official advertising guidance; implied claims, substantiation and testimonial limits
Read the original recordArticles using this source
Accessed 2026-09-27
American Academy of Dermatology — Taking pictures of your skin
Professional-society patient communication guidance; not a marketing-image validation protocol
Read the original recordArticles using this source
Accessed 2026-09-27
FDA — Locate a State-Licensed Online Pharmacy
Official pharmacy identity and license-checking information; not product testing
Read the original record